p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan

Journal of Cancer Research and Clinical Oncology

Volumn 130, Issue 12, 2004, Pages 728-732

  Lung, For Wey ^a   Lee, Tai Min ^a   Shu, Bih Ching ^b   Chang, Fu Hsin ^a  

^a KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Colorectal cancer; Dukes classification; Polymorphism

Indexed keywords

MUTANT PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RISK; CHI SQUARE DISTRIBUTION; CODON; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE CLASSIFICATION; DNA POLYMORPHISM; EXON; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; POPULATION; PRIORITY JOURNAL; SAMPLE; TAIWAN;

ADULT; AGED; BASE SEQUENCE; CODON; COLORECTAL NEOPLASMS; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RISK FACTORS; SEQUENCE ANALYSIS, DNA; TAIWAN;

EID: 12444257757     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-004-0605-4     Document Type: Article

References (24)

1. Buller RE, Sood A, Fullenkamp C, Sorosky J, Powills K, Anderson B (1997) The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis. Cancer Gene Ther 4:239-245
2. Chang FH, Tzeng DS, Lee TM, Chen TC, Hsu LS, Lung FW (2003) Mutations in the p53 tumor suppressor gene in colorectal cancer in Taiwan. Kaohsiung J Med Sci 19:151-158
3. Fearon ER, Hamilton SR, Vogelstein B (1987) Clonal analysis of human colorectal tumors. Science 328:193-197
4. Hao XP, Ilyas M, Talbot IC (1997) Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence. Pathobiology 65:140-145
5. Hao XP, Frayling IM, Sgouros JG, Du MQ, Willcocks TC, Talbot IC, Tomlinson IPM (2002) The spectrum of p53 mutations in colorectal adenomas differs from that in colorectal carcinomas. Int J Gastroenterol Hepatol 56:834-839
6. Harris N, Brill E, Shohat O, Prokocimer M, Wolf D, Arai N, Rotter V (1986) Molecular basis for heterogeneity of the human p53 protein. Mol Cell Biol 6:4650-4656
7. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49-53
8. Jin X, Roth JA, Amos CI, King TM, Branch C, Honn SE, Spitz MR (1995) Higher lung cancer risk for younger African Americans with the Pro/Pro p53 genotype. Carcinogenesis 16:2205-2208
9. Knudson AG (1985) Hereditary cancer, oncogens, and antioncogenes. Cancer Res 45:1437-1743
10. Levine AJ (1993) The tumor suppressor genes. Annu Rev Biochem 62:623-651
11. Levine AJ (1997) P53, the cellular gatekeeper for growth and division. Cell 88:323-331
12. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV (1987) Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7:961-963
13. O'Connor DP, Kay EW, Leader M, Atkins GJ, Murphy GM, Mabruk MJEMF (2001) P53 codon 72 polymorphism and human papillomavirus associated skin cancer. J Clin Pathol 54:539-542
14. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766-2770
15. Pignatelli M, Stamp GW, Kafiri G, Lane D, Bodmer WF (1992) Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Int J Cancer 50:683-688
16. Rosenthal AN, Ryan A, Al-Jehani RM, Storey A, Harwood CA, Jacobs IJ (1998) P53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 352:871-872
17. Russell SB, Trupin KM, Rodriguez-Eaton S, Russell JD, Trupin JS (1988) Reduced growth-factor requirement of keloid derived fibroblasts may account for tumor growth. Proc Natl Acad Sci USA 85:587-591
18. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B (1995) bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55:237-241
19. Sjalander A, Birgander R, Hallmans G, Cajander S, Lenner P, Athlin L, Beckman G, Beckman L (1996) P53 polymorphisms and haplotypes in breast cancer. Carcinogenesis 17:1313-1316
20. Sorensen DM, Lewark TM, Haney JL, Meyers AD, Krause G, Franklin WA (1997) Absence of p53 mutations in squamous carcinomas of the tongue in nonsmoking and nondrinking patients younger than 40 years. Arch Otolaryngol Head Neck Surg 123:503-506
21. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393:229-334
22. Ulrik L, Hanna F, Nikos P, Adel G, Henrik Z, Hans O (2000) Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma. Cancer 88:2661-2667
23. Vogelstein B (1990) Cancer. A deadly inheritance. Nature 348:681-682
24. Wang YC, Lee HS, Chen SK, Chang YY, Chen CY (1999) Prognostic significance of p53 codon 72 polymorphism in lung carcinoma. Eur J Cancer 5:226-230